Examples of using Administered subcutaneously in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Normal donors are given a dose of a 10 μ g/ kg/ day, administered subcutaneously for 4 to 5 consecutive days.
As maintenance treatment, the recommended dose is 10 million IU/ m2 administered subcutaneously three days a week(every other day)
In clinical studies used for registration, a total of 999 HAE attacks have been treated with 30 mg Firazyr administered subcutaneously by a healthcare professional.
Notable differences in the safety profile of VELCADE administered subcutaneously versus intravenously as single agent.
There was no accumulation after multiple dose administration of 600 IU/kg administered subcutaneously weekly.
NeoRecormon should be administered subcutaneously in order to increase haemoglobin to not greater than 12 g/ dl 7.5 mmol/ l.
For patients with a body weight> 100 kg the initial dose is 90 mg administered subcutaneously, followed by a 90 mg dose 4 weeks later, and then every 12 weeks thereafter.
Etanercept is administered subcutaneously once or twice per week,
The recommended posology of STELARA is an initial dose of 45 mg administered subcutaneously, followed by a 45 mg dose 4 weeks later, and then every 12 weeks thereafter.
At a concentration of 0.4 mg/kg/day oxybutynin administered subcutaneously, the occurrence of organ anomalies is significantly increased,
an initial dose of 0.75 μg/kg may be administered subcutaneously as a single injection once every two weeks.
The recommended dosage is 100 I.U. daily or 50 I.U. twice daily for 2 to 4 weeks, administered subcutaneously or intramuscularly.
50 IU/kg twice a week if administered subcutaneously.
S 10 million IU doses administered subcutaneously, at 5 million IU/ m2 administered intramuscularly and as a.
Nespo may be administered subcutaneously once monthly using an initial dose equal to twice the previous once every two week dose.
regular human insulin administered subcutaneously at a dose of 0.15 Units/kg,
The most frequent adverse reactions reported during post-marketing use of recombinant human hyaluronidase in similar formulations administered subcutaneously for the dispersion and absorption of subcutaneously administered fluids or medicinal products have
placebo were administered subcutaneously twice a week for 6 months in 138 patients.
In normal donors, a 10 micrograms/kg/day dose administered subcutaneously for 4- 5 consecutive days allows a collection of≥ 4 x 106 CD34+ cells/kg recipient body weight in the majority of the donors after two leukaphereses.
lowering profiles of insulin glulisine and regular human insulin administered subcutaneously at a dose of 0.15 U/ kg, at.